For international orders (non-US), use this site. For US orders only, visit ArcherDx has discontinued the SureShot Fusion Controls, catalog nos. AK0035-4 and AK0036-4. We do not currently offer an alternative but are committed to providing customers with high-quality support and service. ArcherDx recommends evaluating alternate solutions from Horizon and SeraCare.

Archer® FusionPlex® Solid Tumor Kit

The Archer FusionPlex Solid Tumor Kit is a target-enrichment assay that can be used to create libraries for next generation sequencing and offers a complete fusion detection solution.Read More...
Select Product(s)

Archer FusionPlex Solid Tumor Kit - 8 reactions


Accessory Products

Archer MBC Adapters A17-A24



Archer MBC Adapters A25-A32



Archer MBC Adapters A33-A40



Archer MBC Adapters A41-A48



Product Highlights

The Archer FusionPlex Solid Tumor Kit is a robust targeted sequencing assay to simultaneously detect and identify fusions and other mutations associated with over 50 genes linked to various carcinomas. Also included in the kit are primers that target known sarcoma- and hematological malignancy-associated fusions as well as prominent BRAF and PDGFRA mutations. The power of the FusionPlex Solid Tumor Kit lies in Archer’s proprietary Anchored Multiplex PCR-based enrichment (AMPTM). This chemistry enables detection of all fusions associated with the genes in this kit in a single sequencing assay, even without prior knowledge of fusion partners or breakpoints.

  • Comprehensive - identify carcinoma-related fusions in a single assay
  • Detailed - characterize Fusion partners at single-nucleotide resolution
  • Streamlined - reduce turn-around time and reduce reflex testing
  • Flexible - works with all clinical sample types, including FFPE

See All Illumina Cancer Research Panels

Frequently Purchased Together


Product Literature

Report on FFPE Extraction Methods

White Paper | PDF2 MB

PreSeq RNA QC Assay

White Paper | PDF< 1 MB

Archer FusionPlex Assay Targets

Brochure | PDF1 MB

Archer FusionPlex Solid Tumor

Brochure | PDF1 MB

Manuals and Support Information

All Archer FusionPlex Support 

Related Products

  1. R. A. Weinberg, The Biology of Cancer (Garland Pub, 2007).
  2. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2011 Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2014. Available at
  3. C. Errani et al., A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites. Genes Chromosomes Cancer 50, 644–653 (2011).
  4. M. R. Tanas et al., Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma. Sci Transl Med 3, 98ra82–98ra82 (2011).
  5. G. Pierron et al., A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion. Nat. Genet. 44, 461–466 (2012).